Juno Therapeutics News Timeline

Juno Therapeutics Inc -- USA Stock  

USD 42.88  0.02  0.05%

This is yet another view into Juno Therapeutics filtered headlines to help investors concentrate on Juno Therapeutics Inc noise-free news that matters. Some academic researchers believe in strong correlation between financial news and their impacts to the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Juno Therapeutics headlines in addition to utilizing other more conventional financial analysis modules. Please also check Juno Therapeutics Backtesting and Juno Therapeutics Hype Analysis
news
October 16, 2017
Analyst Projections in Review for Juno Therapeutics, Inc. at finnewsweek.com 
View Story
news
October 16, 2017
-0.34 EPS Expected for Nantkwest Inc at bzweekly.com 
View Story
prnewswire News
October 13, 2017
WEISSLAW LLP Dimension Therapeutics, Inc. Acquisition May Not Be in the Best ... at www.prnewswire.com 
View Story
news
October 13, 2017
VBI Vaccines, Inc. Ordinary S Sees Light Trading Volume with ... at www.modernreaders.com 
View Story